Could a simple breath test spot hidden diseases early?

NCT ID NCT07646015

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is testing a portable, non-invasive breath analyzer that measures tiny particles in exhaled breath to screen for conditions like type 2 diabetes, liver disease, kidney disease, and lung disease. Researchers will enroll healthy volunteers and people with known diagnoses to build and validate AI algorithms that can identify early signs of metabolic problems. The goal is to create an affordable, easy-to-use screening tool that could help catch diseases before symptoms appear.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
smart breath analyzer (non-invasive device measuring volatile organic compounds in exhaled breath)
What this could lead to
If validated, this breath analyzer could offer a quick, painless way to screen for multiple metabolic diseases early, enabling timely preventive care.
What could go wrong
This is an early validation study; the device's accuracy and reliability are not yet proven, and AI algorithms may not perform well across diverse populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dept. of Community Medicine, JSS Medical College

    Mysore, Karnataka, 570015, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.